D. Powars et al., EPIDEMIC MENINGOCOCCEMIA AND PURPURA FULMINANS WITH INDUCED PROTEIN-CDEFICIENCY, Clinical infectious diseases, 17(2), 1993, pp. 254-261
Patients with epidemic infections caused by Neisseria meningitidis ser
ogroup C were studied to assess the relationship of abnormal coagulati
on parameters to prognosis. Patients were categorized into stages with
in the first hour of observation according to severity of illness. Dur
ing the epidemic years 1986 through 1991, 113 patients with bacteriolo
gically proven N. meningitidis infection were observed, 15 of whom die
d. Purpura fulminans was seen in 28 patients, of whom 14 (50%) died. A
mong the 14 surviving patients who had purpura fulminans, 10 suffered
gangrene with deforming autoamputation secondary to the dermal microva
scular thrombosis and hemorrhagic necrosis. Evaluation of the induced
diffuse intravascular coagulation in 59 patients included studies of t
he naturally occurring anticoagulants, focusing on protein C and prote
in S. The magnitude of the declining levels of protein C, the degree o
f thrombocytopenia, and the presence of fibrin split products are dire
ctly related to the clinical severity of the illness (P = .0053). Thus
, in individuals with severe disease expression, the risk of purpura f
ulminans with death or deformity was significantly increased when the
platelet count was <50,000 cells/mm3 (P = .0001) and protein C levels
were low (P = .0158). The immaturity of the protein C system in childr
en who are <4 years of age may contribute to the rapid and more freque
nt pathogenesis of purpura fulminans. Therapy directed at replacement
of the naturally occurring anticoagulants, such as protein C, may ulti
mately improve the prognosis for individuals with purpura fulminans.